SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eun Sook Park, Eungeol Sim, Dong-Wook Rha, Soojin Jung, Architectural Changes of the Gastrocnemius Muscle after Botulinum Toxin Type A Injection in Children with Cerebral Palsy, Yonsei Medical Journal, 2014, 55, 5, 1406

    CrossRef

  2. 2
    Florin Gandor, Stephen Tisch, Anthony J. Grabs, Anthony J. Delaney, Lourens Bester, Paul Darveniza, Botulinum toxin A in functional popliteal entrapment syndrome: a new approach to a difficult diagnosis, Journal of Neural Transmission, 2014, 121, 10, 1297

    CrossRef

  3. 3
    Ali E. El Deeb, Reda El Bakary, Amal A.A. Abd-El-Hafez, Histological characteristics of botulinum neurotoxin-A on rat skeletal muscles, The Egyptian Journal of Histology, 2014, 37, 2, 393

    CrossRef

  4. 4
    Irene Nikaina, Antigone Papavasiliou, Potential of Botulinum toxin A to treat upper extremity spasticity in children with cerebral palsy, Toxin Reviews, 2014, 1

    CrossRef

  5. 5
    Martin Gough, Adam P. Shortland, Cerebral Palsy in Infancy, 2014,

    CrossRef

  6. 6
    Guy Molenaers, Katrien Fagard, Anja Van Campenhout, Kaat Desloovere, Botulinum toxin A treatment of the lower extremities in children with cerebral palsy, Journal of Children's Orthopaedics, 2013, 7, 5, 383

    CrossRef

  7. 7
    Anja Van Campenhout, Ann Verhaegen, Steven Pans, Guy Molenaers, Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: Muscle atrophy after motor end plate-targeted injections, Research in Developmental Disabilities, 2013, 34, 3, 1052

    CrossRef

  8. 8
    A. Roberts, Botulinum toxin: caveat injector, Paediatrics and Child Health, 2013, 23, 9, 414

    CrossRef

  9. 9
    Sîan A. Williams, Catherine Elliott, Jane Valentine, Anna Gubbay, Peter Shipman, Siobhan Reid, Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength, Disability and Rehabilitation, 2013, 35, 7, 596

    CrossRef

  10. 10
    Rafael Fortuna, Monika Horisberger, Marco Aurélio Vaz, Walter Herzog, Do skeletal muscle properties recover following repeat onabotulinum toxin A injections?, Journal of Biomechanics, 2013, 46, 14, 2426

    CrossRef

  11. 11
    Inga K. Koerte, A. Sebastian Schroeder, Urban M. Fietzek, Ingo Borggraefe, Martina Kerscher, Steffen Berweck, Maximilian Reiser, Birgit Ertl-Wagner, Florian Heinen, Muscle Atrophy Beyond the Clinical Effect After a Single Dose of OnabotulinumtoxinA Injected in the Procerus Muscle: A Study with Magnetic Resonance Imaging, Dermatologic Surgery, 2013, 39, 5
  12. 12
    Sîan A Williams, Siobhan Reid, Catherine Elliott, Peter Shipman, Jane Valentine, Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy, Developmental Medicine & Child Neurology, 2013, 55, 9
  13. 13
    Saedeh Dadgar, Zack Ramjan, Wely B. Floriano, Paclitaxel Is an Inhibitor and Its Boron Dipyrromethene Derivative Is a Fluorescent Recognition Agent for Botulinum Neurotoxin Subtype A, Journal of Medicinal Chemistry, 2013, 56, 7, 2791

    CrossRef

  14. 14
    Lee Barber, Tandy Hastings-Ison, Richard Baker, H. Kerr Graham, Rod Barrett, Glen Lichtwark, The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study, Journal of Children's Orthopaedics, 2013, 7, 5, 425

    CrossRef

  15. 15
    Daniel M. Laskin, Botulinum Toxin A in the Treatment of Myofascial Pain and Dysfunction: The Case Against Its Use, Journal of Oral and Maxillofacial Surgery, 2012, 70, 5, 1240

    CrossRef

  16. 16
    Antigone S. Papavasiliou, Irene Nikaina, Panagiotis Bouros, Ioanna Rizou, Constantine Filiopoulos, Botulinum toxin treatment in upper limb spasticity: Treatment consistency, European Journal of Paediatric Neurology, 2012, 16, 3, 237

    CrossRef

  17. 17
    D. Fehlings, U. Narayanan, J. Andersen, R. Beauchamp, J. W. Gorter, A. Kawamura, G. Kiefer, M. Mason, A. McCormick, R. Mesterman, L. Switzer, J. Watt, Botulinum Toxin-A use in Paediatric Hypertonia: Canadian Practice Patterns, The Canadian Journal of Neurological Sciences, 2012, 39, 04, 508

    CrossRef

  18. 18
    Alessandro Picelli, Paola Bonetti, Carla Fontana, Martina Barausse, Francesca Dambruoso, Francesca Gajofatto, Paolo Girardi, Mario Manca, Raffaele Gimigliano, Nicola Smania, Is Spastic Muscle Echo Intensity Related to the Response to Botulinum Toxin Type A in Patients With Stroke? A Cohort Study, Archives of Physical Medicine and Rehabilitation, 2012, 93, 7, 1253

    CrossRef

  19. 19
    Codrin Lungu, Andrew W. Tarulli, Daniel Tarsy, Phillip Mongiovi, Veronique G. Vanderhorst, Seward B. Rutkove, Quantifying muscle asymmetries in cervical dystonia with electrical impedance: A preliminary assessment, Clinical Neurophysiology, 2011, 122, 5, 1027

    CrossRef

  20. 20
    Woffles T.L. Wu, Botulinum Toxins in Clinical Aesthetic Practice, 2011,

    CrossRef

  21. 21
    D. Fehlings, I. Novak, S. Berweck, B. Hoare, N. S. Stott, R. N. Russo, Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement, European Journal of Neurology, 2010, 17,
  22. 22
    A Sebastian Schroeder, Inga Koerte, Steffen Berweck, Birgit Ertl-Wagner, Florian Heinen, How doctors think – and treat with botulinum toxin, Developmental Medicine & Child Neurology, 2010, 52, 9
  23. 23
    John W Dunne, Barbara J Singer, Peter L Silbert, Kevin P Singer, Prolonged vastus lateralis denervation after botulinum toxin type A injection, Movement Disorders, 2010, 25, 3
  24. 24
    Florian Heinen, Kaat Desloovere, A. Sebastian Schroeder, Steffen Berweck, Ingo Borggraefe, Anya van Campenhout, Guro L. Andersen, Resa Aydin, Jules G. Becher, Günther Bernert, Ignacio Martinez Caballero, Lucinda Carr, Emmanuelle Chaleat Valayer, Maria Teresa Desiato, Charlie Fairhurst, Paul Filipetti, Ralph-Ingo Hassink, Ulf Hustedt, Marek Jozwiak, Serdar Ibrahim Kocer, Elisabeth Kolanowski, Ingeborg Krägeloh-Mann, Şehim Kutlay, Helena Mäenpää, Volker Mall, Paul McArthur, Edith Morel, Antigone Papavassiliou, Ignacio Pascual-Pascual, Søren Anker Pedersen, Frank S. Plasschaert, Irene van der Ploeg, Olivier Remy-Neris, Anne Renders, Guiseppe Di Rosa, Maja Steinlin, Kristina Tedroff, Joan Vidal Valls, Elke Viehweger, Guy Molenaers, The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy, European Journal of Paediatric Neurology, 2010, 14, 1, 45

    CrossRef

  25. 25
    A.S. Schröder, K. Huß, S. Berweck, F. Heinen, Botulinumtoxin als Teil einer integrierten Behandlung, Monatsschrift Kinderheilkunde, 2009, 157, 11, 1120

    CrossRef